70 Biggest Movers From Friday

Gainers

• AquaBounty Technologies, Inc. AQB shares surged 118.3 percent to close at $4.89. AquaBounty Technologies disclosed that the FDA has lifted import alert on AquAdvantage Salmon.
• Alliqua BioMedical, Inc. ALQA rose 35.91 percent to close at $3.52.
• Globus Maritime Limited GLBS surged 33.94 percent to close at $4.44.
• DXP Enterprises, Inc. DXPE gained 33.03 percent to close at $42.17 after the company reported Q4 EPS of $0.60, compared to $0.29 last year, and sales of $311 million, compared to $265.627 million last year.
• Tonix Pharmaceuticals Holding Corp. TNXP surged 30.84 percent to close at $2.80 after the company late Thursday announced a new European use patent for its TNX-601 PTSD treatment candidate.
• Stellar Biotechnologies Inc SBOT shares gained 28.33 percent to close at $1.54 on Friday after the company reported a share exchange deal with Edesa Biotech.
• Futu Holdings Limited FHL rose 27.67 percent to close at $15.32.
• Nature's Sunshine Products, Inc. NATR surged 22.35 percent to close at $8.43 after the company reported Q4 EPS of $(0.15) compared to $(0.19) last year, and sales of $97.37 million, compared to $88.29 million last year.
• Ra Pharmaceuticals, Inc. RARX shares rose 18.52 percent to close at $25.98.
• Upland Software, Inc. UPLD gained 18.11 percent to close at $39.91 after the company reported better-than-expected results for its fourth quarter.
• TrovaGene, Inc. TROV shares rose 16.22 percent to close at $4.80 on continued strength after traders on Thursday circulated word of an FDA abstract document for the company's prostate cancer treatment; analysts at Maxim and Noble Financial reiterated bullish positions on the stock.
• AutoWeb, Inc. AUTO rose 14.75 percent to close at $3.89 following Q4 results. B. Riley FBR upgraded AutoWeb from Neutral to Buy and raised the price target from $3.20 to $5.
• Maxar Technologies Inc. MAXR surged 14.1 percent to close at $5.18.
• Aerpio Pharmaceuticals, Inc. ARPO rose 14.01 percent to close at $3.50.
• Phunware Inc. PHUN shares gained 13.83 percent to close at $40.98.
• Big Lots, Inc. BIG shares gained 13.63 percent to close at $36.18 after the company reported higher-than-expected Q4 EPS results and announced a $50 million buyback.
• Selecta Biosciences, Inc. SELB gained 13.3 percent to close at $2.30 after gaining 7.41 percent on Thursday.
• Energy Recovery, Inc. ERII climbed 13.27 percent to close at $8.88 after the company reported higher-than-expected Q4 EPS and sales results.
• SCWorx Corp. WORX rose 13.26 percent to close at $6.75.
• Liquid Media Group Ltd. YVR climbed 12.86 percent to close at $3.1600.
• PEDEVCO Corp. PED rose 12.61 percent to close at $2.50.
• Neonode Inc. NEON shares gained 12.4 percent to close at $2.72.
• Calithera Biosciences, Inc. CALA shares gained 12.3 percent to close at $5.75 following Q4 results.
• The Joint Corp. JYNT climbed 11.9 percent to close at $13.45.
• Red Lion Hotels Corporation RLH shares gained 11.57 percent to close at $8.29 after reporting Q4 results.
• Seelos Therapeutics, Inc. SEEL shares gained 11.51 percent to close at $3.39 after surging 96.13 percent on Thursday. Seelos Therapeutics reported an offering for 15.96 million shares via selling shareholders.
• Funko, Inc. FNKO rose 11.3 percent to close at $19.80.
• IAMGOLD Corporation IAG gained 11.01 percent to close at $3.63.
• Celldex Therapeutics, Inc. CLDX climbed 10.87 percent to close at $5.10 following strong Q4 results.
• IDT Corporation IDT surged 9.11 percent to close at $6.23 following Q2 results.
• MAG Silver Corp. MAG surged 9.11 percent to close at $10.30.
• SAExploration Holdings Inc SAEX gained 8.42 percent to close at $3.99 after the company announced $60 million of new projects in Alaska and Southeast Asia.
• Myomo Inc MYO rose 8.33 percent to close at $1.30 after the company reported Q4 EPS and sales results above analyst estimates.
• Vail Resorts, Inc. MTN gained 7 percent to close at $216.55 after the company reported higher-than-expected Q2 EPS and sales results.
• Costco Wholesale Corporation COST rose 5.09 percent to close at $227.82 after the company reported stronger-than-expected earnings for its fiscal second quarter.

Losers

• Bio-Path Holdings, Inc. BPTH shares fell 45.96 percent to close at $21.00 in a potential sell off after the stock rose nearly 600 percent over the past few trading sessions.
• CHF Solutions, Inc. CHFS shares dipped 45.57 percent to close at $4.30 on Friday after the company filed for a $6.21 million offering.
• Altimmune, Inc. ALT shares declined 36.56 percent to close at $2.88 after surging 50.33 percent on Thursday. Altimmune reported a $14 million registered direct offering.
• NV5 Global, Inc. NVEE shares fell 32.28 percent to close at $52.15 after the company reported lower-than-expected Q4 EPS and sales.
• Diffusion Pharmaceuticals Inc. DFFN dropped 28.57 percent to close at $5.00
• China Internet Nationwide Financial Services Inc. CIFS fell 28.54 percent to close at $3.18.
• Eventbrite Inc EB shares fell 24.55 percent to close at $24.46 after the company reported a wider-than-expected Q4 loss and issued weak earnings forecast.
• Great Elm Capital Group, Inc. GEC shares declined 19.79 percent to close at $3.81.
• JMU Limited JMU tumbled 19.27 percent to close at $2.22.
• Translate Bio, Inc. TBIO shares fell 19.21 percent to close at $7.95.
• AMAG Pharmaceuticals, Inc. AMAG fell 17.71 percent to close at $11.29 after the company reported topline results from its PROLONG trial did not demonstrate any statistically significant difference between the treatment and placebo arms for co-primary endpoints.
• Orion Engineered Carbons, S.A. OEC shares fell 17.24 percent to close at $21.80 following Q4 results.
• El Pollo Loco Holdings, Inc. LOCO shares fell 17.08 percent to close at $12.48 after the company posted downbeat Q4 sales and issued weak FY19 earnings forecast.
• Bioblast Pharma Ltd. ORPN shares dropped 17.05 percent to close at $12.60.
• T2 Biosystems, Inc. TTOO declined 16.56 percent to close at $2.62 following Q4 results.
• American Renal Associates Holdings, Inc. ARA declined 16.39 percent to close at $10.46 after the company announced a delay in its fourth quarter and full year 2018 earnings release.
• Cool Holdings, Inc. AWSM fell 16.2 percent to close at $3.31.
• National Beverage Corp. FIZZ dropped 14.65 percent to close at $58.27 after the company reported lower-than-expected Q3 EPS and sales results; Guggenheim analysts subsequently downgraded the company's stock from 'Neutral' to 'Sell.'
• The Alkaline Water Company Inc. WTER shares dropped 14.06 percent to close at $2.75 after the company priced a 4 million share common stock offering at $2.50 per share.
• Syndax Pharmaceuticals, Inc. SNDX dipped 14.04 percent to close at $5.39 following downbeat Q4 results.
• AcelRx Pharmaceuticals, Inc. ACRX shares tumbled 13.03 percent to close at $3.27 after the company reported less-than-expected Q4 sales results.
• American Outdoor Brands Corp AOBC fell 12.4 percent to close at $9.96 following the release of the company's Q3 earnings.
• OHR Pharmaceutical, Inc. OHRP dropped 12.15 percent to close at $2.53.
• HCI Group, Inc. HCI dipped 12.11 percent to close at $38.12 after reporting Q4 results.
• ION Geophysical Corporation IO shares fell 11.39 percent to close at $12.22.
• Antares Pharma, Inc. ATRS shares tumbled 11.32 percent to close at $3.37.
• Cleveland BioLabs, Inc. CBLI shares declined 11.22 percent to close at $1.74.
• Qualstar Corporation QBAK shares fell 11 percent to close at $5.58 following Q4 results.
• Ability Inc. ABIL dropped 10.89 percent to close at $1.80.
• ZAGG Inc ZAGG shares fell 10.8 percent to close at $10.65.
• Aqua Metals, Inc. AQMS shares fell 10.58 percent to close at $3.55.
• Chembio Diagnostics, Inc. CEMI dropped 10.31 percent to close at $6.00 following weak quarterly earnings.
• Liquidia Technologies, Inc. LQDA dipped 9.67 percent to close at $16.26.
• California Resources Corporation CRC shares dropped 8.4 percent to close at $19.52.
• HTG Molecular Diagnostics Inc HTGM shares fell 7.66 percent to close at $2.41 after the company reported lower-than-expected Q4 sales and issued weak Q1 and FY19 guidance.